Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Demonstrated safety with daily subcutaneous (SC)...
Conference

Demonstrated safety with daily subcutaneous (SC) injections of Kineret (R) (Anakinra "C recombinant interleukin-1 receptor antagonist) in a standard practice population

Authors

Offer RC; Russell A; Choquette D; Pirc L; Cividino A

Volume

62

Pagination

pp. 194-195

Publisher

B M J PUBLISHING GROUP

Publication Date

July 1, 2003

Name of conference

Annual European Congress of Rheumatology

Conference place

LISBON, PORTUGAL

Conference start date

June 18, 2003

Conference proceedings

ANNALS OF THE RHEUMATIC DISEASES

ISSN

0003-4967

Labels